Alan Keller

Efficacy of Pamidronate in Reducing Skeletal Events in Patients with Advanced Multiple Myeloma

James R. Berenson, Alan Lichtenstein, Lester Porter et al. · New England Journal of Medicine · 1996 · 1.1K citations

Medicine, Oncology, Pharmacotherapy +16

Long-term pamidronate treatment of advanced multiple myeloma patients reduces skeletal events. Myeloma Aredia Study Group.

James R. Berenson, Alan Lichtenstein, Lisa A. Porter et al. · Journal of Clinical Oncology · 1998 · 653 citations

Medicine, Pharmacology, Pharmacotherapy +14

Phase III Study of Carboplatin and Paclitaxel Alone or With Sorafenib in Advanced Non–Small-Cell Lung Cancer

Giorgio V. Scagliotti, Silvia Novello, Joachim von Pawel et al. · Journal of Clinical Oncology · 2010 · 454 citations · Full text

Medicine, Oncology, Pharmacology +17

Further Evaluation of Intensified and Increased Total Dose of Cyclophosphamide for the Treatment of Primary Breast Cancer: Findings From National Surgical Adjuvant Breast and Bowel Project B-25

Bernard Fisher, Stewart Anderson, Arthur P. DeCillis et al. · Journal of Clinical Oncology · 1999 · 229 citations

Medicine, Oncology, Pharmacotherapy +16

Randomized Phase III Trial of Pegylated Liposomal Doxorubicin Versus Vinorelbine or Mitomycin C Plus Vinblastine in Women With Taxane-Refractory Advanced Breast Cancer

Alan Keller, Robert Mennel, Vassilis A. Georgoulias et al. · Journal of Clinical Oncology · 2004 · 212 citations · Full text

Medicine, Oncology, Pharmacology +16